What's Happening?
ConnectiveRx, in partnership with EagleForce, has launched ShieldRx, a new solution designed to prevent pharmacy misuse before claims are paid. ShieldRx utilizes real-time intelligence and in-workflow intervention to identify and stop suspect pharmacy activities,
protecting manufacturers' gross-to-net performance. The solution addresses challenges posed by payer tactics and growing pharmacy misuse, which contribute to significant revenue losses for manufacturers. ShieldRx integrates advanced identity and compliance technologies to deliver proactive oversight, ensuring that copay investments are safeguarded and used as intended. The launch of ShieldRx represents a significant advancement in pharmacy monitoring and misuse prevention.
Why It's Important?
The introduction of ShieldRx is a critical development in the pharmaceutical industry, addressing the growing issue of pharmacy misuse and its impact on manufacturers' financial performance. By preventing invalid activities before claims are paid, ShieldRx offers a proactive approach to safeguarding revenue and maintaining program integrity. This solution is particularly important as manufacturers face increasing pressure to protect their financial interests while ensuring patient access to medications. The collaboration between ConnectiveRx and EagleForce highlights the potential for technology-driven solutions to enhance compliance and efficiency in the healthcare sector.
